Paull Robert Bradley 4
4 · Kala Pharmaceuticals, Inc. · Filed Jun 29, 2020
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Common Stock
2020-06-25+20,000→ 20,000 total
Holdings
- 2,361(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the earlier of (i) June 25, 2021 or (ii) the date of the first annual meeting following June 25, 2020.
- [F2]Includes 20,000 unvested RSUs
- [F3]These shares are owned directly by the Paull Revocable Trust U/A/D 04/06/2012 (the "Trust"), and indirectly by Mr. Paull as co-trustee of the Trust.